Hemagen Financial Statements From 2010 to 2026

HMGN Stock  USD 0.0001  0.00  0.00%   
Hemagen Diagnostics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Hemagen Diagnostics' valuation are provided below:
Hemagen Diagnostics does not presently have any fundamental trends for analysis.
Check Hemagen Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hemagen Diagnostics' main balance sheet or income statement drivers, such as , as well as many indicators such as . Hemagen financial statements analysis is a perfect complement when working with Hemagen Diagnostics Valuation or Volatility modules.
  
This module can also supplement various Hemagen Diagnostics Technical models . Check out the analysis of Hemagen Diagnostics Correlation against competitors.

Pair Trading with Hemagen Diagnostics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Hemagen Diagnostics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hemagen Diagnostics will appreciate offsetting losses from the drop in the long position's value.

Moving against Hemagen Pink Sheet

  0.59HD Home DepotPairCorr
  0.55PG Procter GamblePairCorr
  0.46BKRKY Bank RakyatPairCorr
  0.37CVX Chevron CorpPairCorr
The ability to find closely correlated positions to Hemagen Diagnostics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Hemagen Diagnostics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Hemagen Diagnostics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Hemagen Diagnostics to buy it.
The correlation of Hemagen Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Hemagen Diagnostics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Hemagen Diagnostics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Hemagen Diagnostics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Hemagen Pink Sheet

Hemagen Diagnostics financial ratios help investors to determine whether Hemagen Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hemagen with respect to the benefits of owning Hemagen Diagnostics security.